Evaluation of rotavirus vaccine administration among a 22q11.2DS patient population
Abstract Background 22q11.2 Deletion Syndrome (22q11.2DS) can result in array of congenital abnormalities including immune dysfunction. International guidelines recommend immune evaluation of 22q11.2DS patients prior to live vaccine administration. A rotavirus vaccination program for infants aged 2...
Main Authors: | Sophie McGregor, Matthew Boroditsky, Geraldine Blanchard-Rohner, Christine Loock, Kyla Jade Hildebrand |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-06-01
|
Series: | Allergy, Asthma & Clinical Immunology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13223-022-00693-z |
Similar Items
-
Consequences of 22q11.2 Microdeletion on the Genome, Individual and Population Levels
by: Małgorzata Karbarz
Published: (2020-08-01) -
Parental experiences and needs of caring for a child with 22q11.2 deletion syndrome
by: Dariusz Walkowiak, et al.
Published: (2023-12-01) -
Quantifying the resolution of spatial and temporal representation in children with 22q11.2 deletion syndrome
by: Kathryn L. McCabe, et al.
Published: (2019-12-01) -
Genotypic and phenotypic variability of 22q11.2 microdeletions – an institutional experience
by: Gabrielle C. Manno, et al.
Published: (2021-12-01) -
Language Profiles of School-Aged Children with 22q11.2 Copy Number Variants
by: Jente Verbesselt, et al.
Published: (2023-03-01)